Shake the hand of someone who… 🤝 Part ONE! Connecting across disciplines, experiences, and a shared mission to move kidney cancer research forward. #IKCSEU26 #KidneyCancer #Oncology #CancerResearch

DAY Two of OncoAlert 🚨 Coverage of #IKCSEU26 Provider Perceptions of Cure in Renal Cell Cancer Presented by Ms. Dena Battle🇺🇸 of @kcCURE RCC specialists demonstrate notable hesitancy in using the term “cure,” even in clinical contexts where long-term outcomes may justify it. This reluctance reflects not only clinical uncertainty but also parallels similar reservations among patients. The absence of a standardized definition contributes to inconsistent communication, potentially affecting expectations and decision-making. Establishing clearer, consensus-driven terminology around “cure” in RCC could enhance transparency, improve physician–patient alignment, and support more informed shared decision-making. Addressing this linguistic and conceptual gap may ultimately strengthen trust and facilitate more meaningful discussions about prognosis and treatment goals in renal cell carcinoma care. #KidneyCancer @KidneyCancer Jean-Christophe Bernhard @univbordeaux @AlbigesL @gustaveroussy @TiansterZhang @Dr_SabyGeorge @ZakhariaYousef @ERPlimackMD @Ric_Campi @DrIacovelli @RebuzziSara @weoncologists @GEVaughan1 @salvolarosa @DrYukselUrun #KidneyCancer @daniyal_jafree @EJonasch @IKCCorg @sophiemerrick1 @BarbaraJereczek @ESTRO_RT @ZakhariaYousef @kuraoncology @Selcuk__Erdem @drulkav @RCCadvocate

Still time to register! Join us this Thursday in Center City for a phenomenal, practice-changing review of everything happening in GU Oncology - and yes, a great meal too!

Doctors! Tell us YOUR answer! How should the term “cure” be used in #kidneycancer? #ESMO25 Let’s see how many responses we can get! @DrChoueiri @montypal @DrYukselUrun @TiansterZhang @Uromigos @OncoAlert surveymonkey.com/r/MDCure

#ESMO25 starts today! Excited to present #evidencebased data from @kcCURE exploring how metastatic #kidneycancer pts interpret the word “cure.”

#KidneyCancer Patients want cures—but few believe they’re possible. Learn what patients living with metastatic RCC think about the word “cure." 📍Abstract 2636P | #ESMO25 #KidneyCancer #mRCC @TiansterZhang @spsutkaMD @DrVaishampayan @MichaelStaehler @lisapic @AlbigesL

It’s hard to believe Americas 🇺🇸 🇨🇦 3-0 down in the Uromigos Cup 🏆 . Weekly photos from each team from around the world wins points . ❤️ =points. Can the Americas 🇺🇸🇨🇦 catch up ? Here is @walterstadler5 in Chicago. @OncoAlert @montypal @crisuarez08 @DrChoueiri

Final analysis of Checkmate 9ER in @Annals_Oncology : 1L mRCC trial annalsofoncology.org/article…

I am delighted and honored to join the great team @RushUrology @RushMedical I want to thank my colleagues @UCSDHealth and @UCSD_Urology #Chicago here I come! #KidneyCancer #UrologicOncology @UroOnc @AmerUrol @EECherullo @cjkane10

Phase 2 trial: In oligometastatic clear-cell RCC, serial metastasis-directed therapy (no systemic Tx) achieved median 34 mo systemic therapy-free survival & 17.7 mo PFS with low grade 3–4 toxicity. A promising option for select pts. 🔎To finish discussion need to 3 arms phase-3 trial: 👉MDT only vs. Systemic Tx only vs. MDT Systemic Tx @OncoAlert @TheLancet #cancer #Oncology #MedX doi.org/10.1016/S1470-2045(2…

Just came online in @TheLancet 👉Our two papers on improved OS with Enzalutamide Talazoparib in mCRPC #ProstateCancer in all-comer & HRRm patients (Median OS and HRs👇). Weblinks to the papers👉 bit.ly/4lXkLtB and bit.ly/4nNIyOh @PCFnews @urotoday @OncoAlert

Join Dr. Sumanta Kumar Pal (@montypal) & colleagues on Saturday, May 31, at 6:30 PM CDT/7:30 PM EDT during #ASCO25 for a #RenalCellCarcinoma #MedEd event. Produced with @KCCure. bit.ly/4mdScJu #KidneyCancer #Oncology

📣 Live at #ASCO25: Learn from real-world #RCC cases with @montypal, Dr. McDermott & @TiansterZhang  ✅ IO-based regimens  ✅ Sequencing therapies  ✅ Shared decision-making  🗓️ May 31 | 7:00 PM CDT  🔗 bit.ly/RCC-T

Just a week away! Please join us in Chicago at this Peerview event, 7pm central on Sat 5/31! Register here: lrn.peerview.com/150210496_1…

Great job @KidneyCancerJ! Do not miss all the research articles from Linnea Olsson, @MichaelStaehler @LauraBukavinaMD David Jin, Lars Lund. Thank you all for your contributions!!

Glimpses of #IKCSEU25!

Congratulations @MichaelStaehler, recipient of #FitzgeraldAward @KidneyCancer #IKCSEU25! Legacy and innovation. Sets challenges and vision for our field to find the right patients for the right treatments.

Good morning everyone, #IKCSEU25 begins TODAY 🎊 🎉 We are excited to come together here in Amsterdam talk about the future of #kidneycancer and how best to care for the patients who are counting on us. Looking forward to the next few days!

🎉CONGRATULATIONS to @MichaelStaehler, recipient of the KCA's 2025 John Fitzpatrick Award recognizing excellence in urology care! The award will be presented at #IKCSEU25, don't miss his lecture! kidneycancer.swoogo.com/IKCS…

One day left for early registration to attend the 2025 IKCS: Europe! #IKCSEU25 See you in Amsterdam, May 1-3 for an exciting #kidneycancer meeting and the opportunity to network with others passionate about making a difference for patients! Register: kidneycancer.org/event/2025-…